Novo Nordisk India revises pricing to make vital therapies more affordable for patients managing diabetes and obesity ...

Nina Notman meets the scientists developing recombinant antivenoms and small molecule inhibitors to save the lives and limbs of snakebite patients, who number in the their hundreds of thousands ...

Commercial launch of AlbuFree™ DX recombinant human albumin by Proliant Health & Biologicals using Dyadic’s production ...

Rising demand for recombinant proteins, automation-ready cloning workflows, and AI-integrated molecular biology kits accelerates market growth at a CAGR of 10.68%.Austin, United States, March 25, 2026 ...

Since I stepped into the President’s role in June 2025, our focus has been very clear: to accelerate Dyadic International, Inc.’s transition from a development-stage platform company into a commercial ...

French precision fermentation startup Standing Ovation has raised €30M ($34.2M) in new funding to commercialise its ...

Commercial launch of AlbuFree DX recombinant human albumin by Proliant Health & Biologicals using Dyadic's production platform, with Dyadic eligible to receive a share of profits from product salesExp ...

BIO-Europe Spring 2026 brought together more than 3,700 innovators in the life sciences industry all under the same roof.

Learn how synthetic promoters bring innovation to gene expression, enhancing performance and safety in biotechnology ...

But without insulin the sugar can’t be used, so the starvation response continues, and the body resorts to burning fatty ...

DNA robots are emerging as tiny programmable machines that could one day deliver drugs, hunt viruses, and build ...

Scientists have uncovered a surprising secret about our DNA: it’s not a static blueprint, but a constantly shifting, folding ...